Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/11/21
End: 01/08/24
Due: 01/08/25
Phase: N/A
Priority: Normal
Start: 09/28/17
End: 11/01/23
Due: 11/01/24
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 07/31/12
Due: 07/31/13
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients | NCT04961658 | Northern Therapeutics | user2@example.com | None | 2021-08-11 | 2024-01-08 | 2025-01-08 | - | - | 2025-07-14 |
| Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension | NCT03001414 | Northern Therapeutics | user2@example.com | None | 2017-09-28 | 2023-11-01 | 2024-11-01 | - | - | 2025-07-14 |
| Pulmonary Hypertension: Assessment of Cell Therapy | NCT00469027 | Northern Therapeutics | user2@example.com | None | 2006-05-31 | 2012-07-31 | 2013-07-31 | - | - | 2025-07-14 |